Fig. 1: TC2N overexpression in BC predicts better OS and is a valuable prognostic marker of patients with BC.
From: Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer
a Oncomine BC datasets showing that the mRNA expression levels of TC2N were upregulated in BC tissues. b IHC analysis of TC2N protein expression in 75 BC tissues and paired adjacent non-tumor tissues. Scale bars, 20 μm. c The protein expression of TC2N was detected in BC patients with different stage of tumor. d The protein expression of TC2N was detected in the different stages of BC patients with or without lymphatic metastasis. e The protein expression of TC2N was detected in BC patients with different size of tumor. f Kaplan–Meier analysis of the correlation between TC2N expression and overall survival time in 75 BC patients. *P < 0.05; **P < 0.01
